Here are Friday’s biggest analyst calls: Nvidia, Apple, Dell, Netflix, Micron, Broadcom, Eli Lilly, New York Community Bancorp & more
Here are the biggest calls on Wall Street on Source link
Read More
Eli Lilly and Co
5 things to know before the stock market opens Thursday
Here are the most important news items that investors need to start their trading day. Source link
Read More
Viking stock doubled Tuesday. Here’s where the next moves in the obesity space could come from
Anti-obesity drugmakers Novo Nordisk and Eli Lilly have a huge lead on their competition, but it's coming. Source link
Read More
This Marsico fund has outperformed lately by finding the best growth stories
The fund has outperformed both the S&P 500 and Nasdaq Composite year to date. Source link
Read More
New sickle cell gene therapies are a breakthrough, but solving how to pay their high prices is a struggle
Breakthrough sickle cell treatments are available in the U.S., but their high cost is forcing insurers to get creative. Source
Read More
Pharma stocks have quietly outperformed. Here’s one way to play the space
Pharmaceutical stocks have exhibited positive relative strength in recent weeks after significant underperformance in the fourth quarter of last year.
Read More
Morgan Stanley ponders if Eli Lilly could be the first $1 trillion pharma stock on weight loss boom
Eli Lilly's 'diabesity' medications are positioning it to become the first pharmaceutical company to hit $1 trillion in market cap,
Read More
What Eli Lilly investors can learn from the slow launch of a competitor’s drug
The rollout of Alzheimer's treatment Leqembi from Biogen is going slower than expected, providing a read-through for Club stock Eli
Read More
Phillippe Laffont’s Coatue shifted money in technology amid fourth quarter rally
See where the Tiger Cub fund manager added and lowered exposure within technology. Source link
Read More